These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7296922)

  • 1. [Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
    Yoshinaga K; Arakawa K; Ikeda M; Ebihara T; Oe N
    Horumon To Rinsho; 1981 Apr; 29(4):515-22. PubMed ID: 7296922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effects of labetalol on pheochromocytoma].
    Yoshinaga K; Arakawa K; Ando H; Iai F; Ikeda M
    Horumon To Rinsho; 1983 Feb; 31(2):183-92. PubMed ID: 6340865
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant pheochromocytoma: blood pressure controlled by labetalol].
    Sugano O; Hirano J; Hirano K; Kubota Y; Numasawa K; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):523-7. PubMed ID: 6471663
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
    Reach G; Thibonnier M; Chevillard C; Corvol P; Milliez P
    Br Med J; 1980 May; 280(6227):1300-1. PubMed ID: 7388518
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pheochromocytoma treated with combined alpha-beta blockader].
    Nyberg G; Waldenström J; Vedin A
    Lakartidningen; 1979 Jun; 76(23):2248-50. PubMed ID: 459631
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertensive response to labetalol in phaeochromocytoma.
    Briggs RS; Birtwell AJ; Pohl JE
    Lancet; 1978 May; 1(8072):1045-6. PubMed ID: 76965
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol and phaeochromocytoma.
    Navaratnarajah M; White DC
    Br J Anaesth; 1984 Oct; 56(10):1179. PubMed ID: 6477797
    [No Abstract]   [Full Text] [Related]  

  • 9. [Labetalol in the intraoperative control of pheochromocytoma].
    Janjić I; Luetić V
    Lijec Vjesn; 1983; 105(7-8):304-6. PubMed ID: 6633151
    [No Abstract]   [Full Text] [Related]  

  • 10. Labetalol in the preoperative management of phaeochromocytoma.
    Russell WJ; Kaines AH; Hooper MJ; Frewin DB
    Anaesth Intensive Care; 1982 May; 10(2):160-3. PubMed ID: 6125109
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)].
    Rumboldt Z; Bagatin J; Vidović A
    Lijec Vjesn; 1980 Nov; 102(11):619-23. PubMed ID: 7024692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

  • 13. Falsely high urinary catecholamines induced by labetalol.
    Kobayashi K; Miura Y; Tomioka H; Sakuma H; Adachi M; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):63-9. PubMed ID: 760251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of labetalol during anesthesia for pheochromocytoma removal.
    Van Stratum M; Levarlet M; Lambilliotte JP; Lignian H; de Rood M
    Acta Anaesthesiol Belg; 1983 Dec; 34(4):233-40. PubMed ID: 6673473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol in the treatment of a patient with phaechromocytoma: a case report.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):141S-142S. PubMed ID: 526394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

  • 17. [Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
    El Matri A; Larabi MS; Kheder A; Belkahia C; Kechrid C; Ben Maiz H; Ben Ayed H
    Nouv Presse Med; 1982 May; 11(21):1611-3. PubMed ID: 7048251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.
    Kaufman L
    Br J Clin Pharmacol; 1979; 8(Suppl 2):229S-232S. PubMed ID: 526406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].
    Matsuura H; Koyama S; Tsuchioka Y; Yoshida M; Kurogane H
    Horumon To Rinsho; 1982 Dec; 30(12):1439-46. PubMed ID: 6130862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of pheochromocytoma].
    Coruzzi P; Novarini A
    Ann Ital Med Int; 1989; 4(3):224-9. PubMed ID: 2577152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.